Company intelligence / Profile preview

AgBioChem

California, United Statesagbiochem.com ↗

Ownership: Private
Development stage: Commercial

Overview

AgBioChem provides commercial products for the prevention and control of crown gall disease in a wide range of economically important crops. Their solutions are used by growers to reduce losses from this plant "cancer," which affects almonds, walnuts, stone fruits, grapes, berries, ornamentals and more.

Therapeutic areas: Infectious Diseases
Modalities: BiologicSmall molecule
Industry: Agriculture & AgTech

Drug pipeline

2 assets

GALLTROL-A

Commercial

Indications: Crown gall disease prevention

1 more asset in the full pipeline.

Request access →

Partnerships

No major pharmaceutical or biotech partnerships identified; operates independently as a small family-owned business

Beyond the preview

Go deeper on AgBioChem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AgBioChem.

Explore the full profile